wmedicinereport.com
Home » Medications »
A federal judge has ruled that state and local governments cannot publicize federal government data about where prescription opioids were distributed—a blow to news organizations seeking to report more deeply on the nation’s overdose and addiction crisis. The U.S. Drug Enforcement Agency is providing the information to state and local governments to use in their lawsuits against companies that make, […]
Read more
With the Walmart Rx Program, you can get select generic medications at $4 for a 30-day supply and $10 for a 90-day supply. It doesn’t require a membership, and these low cash prices are available with or without insurance. All you need to do is take your prescription to a Walmart pharmacy counter and speak with your pharmacist about their […]
Read more
NORTH CHICAGO, Ill., July 24, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), announced that the U.S. Food and Drug Administration (FDA) approved Orilissa (elagolix), the first and only oral gonadotropin-releasing hormone (GnRH) antagonist specifically developed for women with moderate to severe endometriosis pain.1,2 The FDA approved Orilissa under […]
Read more
July 18, 2018 – Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that a 16-week Phase 3 study in patients with osteoarthritis (OA) pain evaluating subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, met all three co-primary endpoints. The study demonstrated that patients who received two doses of tanezumab separated by eight weeks experienced a statistically […]
Read more
The Chinese manufacturer of a widely used blood pressure medication said it had launched a global recall after US and European regulators warned of contamination by a cancer-causing impurity. The European Medicines Agency (EMA) first issued an alert on July 5 over supplies of the active ingredient valsartan produced by Zhejiang Huahai Pharmaceutical Company, based in eastern China and listed […]
Read more
MADISON, Wis., July 09, 2018 (GLOBE NEWSWIRE) — Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, announces that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to CLR 131, the company’s lead Phospholipid Drug Conjugate™ (PDC) product […]
Read more
We need to talk. I’ve been noticing that you sometimes don’t pick up your refills. Often times, you’re shocked at the high price of your prescriptions. Other times, you’re frustrated because you have to wait a long time in line or your prescription isn’t ready. Believe it or not, I get it. I want to help you be healthy, and […]
Read more
1) Pack allergy medications Refill prescriptions and/or over-the-counter medications for allergy symptoms like sinus pain and pressure. If you’ll be flying, a decongestant like Sudafed (pseudoephedrine) and saline sprays can be helpful to keep your nasal membranes moist. Pack your medications, keeping their original labels on, and bring duplicate prescriptions if possible in case you lose any. When checking-in for […]
Read more
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed. Researchers at UNSW Sydney who conducted one of the world’s longest community studies of its type have found no clear role for cannabis in treating chronic non-cancer pain. The study, funded by the National Health and Medical Research Council and led by […]
Read more
CAMBRIDGE, Mass., June 21, 2018 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced it has dosed the first patient in the VOYAGER Phase 3 clinical trial, which is evaluating the safety and efficacy of avapritinib compared to regorafenib in patients with advanced gastrointestinal stromal […]
Read more